The diagnostic value of serum miRNAs and preoperative prediction of tumor subtype in patients with early-stage non-small cell lung cancer

Zhu Wang-Yu; Fang Ke-Xing; Le Han-bo; Zhang Yong-Kui

首页> 外文期刊>International journal of molecular medicine >The diagnostic value of serum miRNAs and preoperative prediction of tumor subtype in patients with early-stage non-small cell lung cancer

【24h】

The diagnostic value of serum miRNAs and preoperative prediction of tumor subtype in patients with early-stage non-small cell lung cancer

机译：早期非小细胞肺癌患者肿瘤亚型血清MIRNA和术前预测的诊断价值

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International journal of molecular medicine》 |2017年第1期|共1页
作者
Zhu Wang-Yu; Fang Ke-Xing; Le Han-bo; Zhang Yong-Kui;
展开▼
作者单位

Wenzhou Med Univ Zhoushan Hosp Dept Cardiothorac Surg Zhoushan Zhejiang Peoples R China;

Wenzhou Med Univ Zhoushan Hosp Cellular &

Mol Biol Lab Zhoushan Zhejiang Peoples R China;

Wenzhou Med Univ Zhoushan Hosp Dept Cardiothorac Surg Zhoushan Zhejiang Peoples R China;

Wenzhou Med Univ Zhoushan Hosp Dept Cardiothorac Surg Zhoushan Zhejiang Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. The diagnostic value of serum miRNAs and preoperative prediction of tumor subtype in patients with early-stage non-small cell lung cancer [J] . Zhu Wang-Yu, Fang Ke-Xing, Le Han-bo, International journal of molecular medicine . 2017,第Suppla1期

机译：早期非小细胞肺癌患者肿瘤亚型血清MIRNA和术前预测的诊断价值
2. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer [J] . Fan Lihong, Qi Huiwei, Teng Junliang, Tumour biology : . 2016,第6期

机译：通过纳米量子点微阵列鉴定血清miRNAs作为诊断性生物标记物，用于早期检测非小细胞肺癌
3. 21LBA Assessing the value of preoperative chemotherapy in early-stage non-small cell lung cancer: mature data and prognostic factors analysis of a Phase III randomized trial of surgery alone vs preoperative Paclitaxel/Carboplatin (PC) vs postoperative PC. Final NATCH data. A Spanish Lung Cancer Group Trial [J] . B.Massuti, J.M.Sanchez, G.Alonso, European Journal of Cancer Supplements . 2009,第3期

机译：21LBA评估术前早期非小细胞肺癌化疗的价值：一项单独的手术，术前紫杉醇/卡铂（PC）与术后PC的III期随机试验的成熟数据和预后因素分析。最终的NATCH数据。西班牙肺癌小组审判
4. IMPROVING PREDICTION OF SURVIVAL USING CT-BASED TUMOR CHARACTERISTICS IN PATIENTS TREATED FOR METASTATIC NON-SMALL CELL LUNG CANCER [C] . WALKER H. LAND JR., ALAN LITWIN, DAN MARGOLIS, Artificial Neural Networks in Engineering Conference . 2010

机译：基于CT基肿瘤特征改善对转移性非小细胞肺癌的患者的肿瘤特征预测
5. The role of NAD(P)H:quinone oxidoreductase 1 in non-small cell lung cancer tumorigenesis and lung cancer stem cell maintenance [D] . Madajewski, Brian. 2016

机译：NAD（P）H：醌氧化还原酶1在非小细胞肺癌的发生和肺癌干细胞维持中的作用
6. Serum Extracellular Vesicle-Derived miRNAs in Patients with Non-Small Cell Lung Cancer—Search for Non-Invasive Diagnostic Biomarkers [O] . Jolanta Kryczka, Monika Migdalska-Sęk, Jacek Kordiak, 2021

机译：非小细胞肺癌患者血清细胞外囊泡衍生的miRNA - 搜查非侵入性诊断生物标志物
7. Tumor-derived exosomal miR-155-5p and miR-658 in serum as diagnostic biomarkers for early-stage non-small cell lung cancer [O] . ZhiJun Zhang, XingGuo Song, Li Xie, 2020

机译：血清中肿瘤衍生的外泌体miR-155-5p和miR-658，作为早期非小细胞肺癌的诊断生物标志物

The diagnostic value of serum miRNAs and preoperative prediction of tumor subtype in patients with early-stage non-small cell lung cancer

著录项

相似文献

相关主题

期刊订阅